During the past decade, Hefei high-tech cardiovascular hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hefei high-tech cardiovascular hospital" #1 collaborator was "Shanghai Shape Memory Alloy Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hefei high-tech cardiovascular hospital" are "Transcatheter Aortic Valve Replacement" (1 trials) and "Ventricular Septal Defect" (1 trials). Many other conditions were trialed in "Hefei high-tech cardiovascular hospital" in a lesser frequency.

Most popular intervention types in "Hefei high-tech cardiovascular hospital" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fully Absorbable VSD Occlusion System" (1 trials), "SinocrownTM Transcatheter Aortic Valve Replacement System" (1 trials) and "VSD Occluder" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hefei high-tech cardiovascular hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hefei high-tech cardiovascular hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Hefei high-tech cardiovascular hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hefei high-tech cardiovascular hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".